ProPharma Group Executive and Leadership Team

June, 2026

Leadership Overview

ProPharma Group has 8 executives leading key functions including finance, operations, information technology, human resources, and multiple president roles driving specialized solutions.

Dedicated to advancing the medical industry through expert guidance, ProPharma Group provides comprehensive regulatory and compliance solutions, ensuring client success in a complex market.

Leadership Roles at ProPharma Group

  • Chief Financial Officer - Jon Otterberg
  • Chief Operating Officer - Patrice Cave
  • President - Jason DeGoes
  • President, Clinical Research Solutions - Daniel Ryan
  • President Life Science Consulting - James Kolbet
  • President, Pharmacovigilance - Laura Hopper
  • Chief Information Officer - Kirk Wroblewski
  • Chief Human Resources Officer - Rachel Bias
  • Jon Otterberg - Chief Financial Officer

    Jon Otterberg, the Chief Financial Officer at ProPharma Group, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Otterberg ensures robust financial health and resource allocation across the organization. This leadership position involves managing investment strategies and optimizing capital structure to support ProPharma Group's growth objectives. By implementing stringent financial controls and driving efficiency, Jon Otterberg directly contributes to the company's sustained profitability and market competitiveness. The Chief Financial Officer's role is critical in guiding financial decisions that align with the company's mission of providing regulatory and compliance solutions to the medical industry. This executive ensures fiscal responsibility and supports long-term value creation for stakeholders through meticulous financial oversight and strategic financial management.

    Patrice Cave - Chief Operating Officer

    Patrice Cave, the Chief Operating Officer at ProPharma Group, oversees all day-to-day operational activities and drives organizational efficiency. Managing critical business processes and ensuring seamless service delivery, Cave aligns operational strategies with ProPharma Group's core mission. This role involves optimizing resource utilization and implementing best practices across departments to enhance productivity and client satisfaction. By directing operational improvements and fostering a culture of excellence, Patrice Cave ensures that ProPharma Group effectively supports the medical industry's regulatory and compliance needs. The Chief Operating Officer's focus is on executing strategic initiatives that enhance the company's operational capabilities and expand its market reach. This executive's leadership ensures the reliable and effective provision of consulting services, directly impacting the company's ability to meet client demands and achieve business objectives.
    Patrice Cave

    Jason DeGoes - President

    Jason DeGoes, the President at ProPharma Group, drives strategic growth and operational excellence across key business units. Overseeing market expansion and client engagement, DeGoes ensures ProPharma Group's comprehensive regulatory and compliance solutions effectively meet the evolving needs of the medical industry. This leadership position involves fostering cross-functional collaboration and championing innovation to enhance service offerings. By guiding strategic initiatives and cultivating strong client relationships, Jason DeGoes directly contributes to the company's market leadership and sustained success. The President's role is critical in translating corporate strategy into actionable plans that deliver tangible results and reinforce ProPharma Group's commitment to client success. This executive's vision shapes the company's trajectory and market impact.

    Daniel Ryan - President, Clinical Research Solutions

    Daniel Ryan, the President, Clinical Research Solutions at ProPharma Group, directs the strategic development and delivery of specialized services for clinical research. Overseeing all aspects of clinical trial support and regulatory guidance, Ryan ensures ProPharma Group's offerings meet the highest industry standards. This leadership role involves driving innovation in clinical research methodologies and expanding service capabilities to support pharmaceutical and biotechnology clients. By focusing on operational efficiency and scientific rigor, Daniel Ryan directly enhances the value ProPharma Group provides to its clients in the medical sector. The President, Clinical Research Solutions' expertise is crucial for navigating the complex regulatory landscape and ensuring successful clinical trial outcomes. This executive's leadership strengthens ProPharma Group's position as a premier provider of clinical research support.
    Daniel Ryan

    James Kolbet - President Life Science Consulting

    James Kolbet, the President Life Science Consulting at ProPharma Group, leads the strategic direction and operational execution of life science consulting services. Overseeing a team of experts, Kolbet ensures the delivery of high-impact regulatory and compliance solutions tailored to the unique challenges of the life science industry. This position involves driving business development and fostering client partnerships to expand ProPharma Group's reach and influence. By focusing on strategic advisory and problem-solving, James Kolbet directly contributes to client success and the company's growth in the life science sector. The President Life Science Consulting's deep industry knowledge is essential for guiding clients through complex regulatory environments. This executive's leadership solidifies ProPharma Group's reputation for excellence in life science consulting.
    James Kolbet

    Laura Hopper - President, Pharmacovigilance

    Laura Hopper, the President, Pharmacovigilance at ProPharma Group, spearheads the strategic vision and operational management of pharmacovigilance services. Overseeing global safety monitoring and regulatory compliance for pharmaceutical products, Hopper ensures the highest standards of patient safety and data integrity. This critical role involves leading teams dedicated to post-market surveillance and risk management, directly supporting ProPharma Group's mission in the medical industry. By implementing robust safety systems and driving continuous improvement, Laura Hopper enhances the company's ability to provide comprehensive pharmacovigilance solutions. The President, Pharmacovigilance's expertise is vital for navigating complex global regulations and safeguarding public health. This executive's leadership strengthens ProPharma Group's commitment to safety and compliance.

    Kirk Wroblewski - Chief Information Officer

    Kirk Wroblewski, the Chief Information Officer at ProPharma Group, architects and manages the company's technology infrastructure and digital strategy. Overseeing all IT operations, cybersecurity, and data management, Wroblewski ensures the secure and efficient flow of information critical to ProPharma Group's services. This position involves driving technological innovation to enhance service delivery and support the company's regulatory and compliance solutions for the medical industry. By implementing advanced IT systems and safeguarding sensitive data, Kirk Wroblewski directly supports operational continuity and client trust. The Chief Information Officer's strategic vision is essential for leveraging technology to achieve business goals and maintain a competitive edge in the market. This executive's leadership ensures that ProPharma Group remains at the forefront of technological advancements, providing secure and reliable solutions.

    Rachel Bias - Chief Human Resources Officer

    Rachel Bias, the Chief Human Resources Officer at ProPharma Group, leads all human capital strategies and organizational development initiatives. Overseeing talent acquisition, employee relations, and compensation and benefits, Bias cultivates a high-performing workforce aligned with ProPharma Group's mission. This role is pivotal in fostering a positive and productive work environment that supports the delivery of expert regulatory and compliance solutions. By developing robust HR policies and programs, Rachel Bias ensures that ProPharma Group attracts, retains, and develops top talent. The Chief Human Resources Officer's strategic focus on employee engagement and professional growth directly contributes to the company's ability to serve the medical industry effectively. This executive's leadership is fundamental to building and maintaining a skilled and motivated team.
    Rachel Bias

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding ProPharma Group Top Executives and Leadership Team

    Who leads ProPharma Group?
    ProPharma Group is led by Jon Otterberg (Chief Financial Officer), along with executives such as Patrice Cave (Chief Operating Officer) and Jason DeGoes (President).
    Who is part of ProPharma Group’s executive team?
    The executive team of ProPharma Group includes leaders such as Jon Otterberg (Chief Financial Officer), Patrice Cave (Chief Operating Officer), Jason DeGoes (President) and other senior executives.
    How many executives does ProPharma Group have?
    ProPharma Group has 8 executives leading key business areas.
    What roles are included in ProPharma Group’s leadership team?
    The leadership team of ProPharma Group includes roles such as Chief Financial Officer, Chief Operating Officer, President, President, Clinical Research Solutions, President Life Science Consulting.